**Core Concept**
Hand and foot syndrome, also known as palmar-plantar erythrodysesthesia, is a cutaneous toxicity associated with certain chemotherapeutic agents. It is characterized by erythema, edema, and sometimes ulceration of the palms and soles. The pathophysiology of hand and foot syndrome is not fully understood, but it is believed to involve damage to the rapidly dividing cells of the skin.

**Why the Correct Answer is Right**
The correct answer is associated with the inhibition of thymidylate synthase, an enzyme involved in DNA synthesis. This inhibition leads to a decrease in thymidine production, which in turn causes damage to rapidly dividing cells, including those in the skin. The correct answer is a chemotherapeutic agent that is known to cause hand and foot syndrome as a side effect.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not associated with hand and foot syndrome. While it is a chemotherapeutic agent, it is more commonly associated with other side effects such as myelosuppression and mucositis.
**Option B:** This option is incorrect because it is not a chemotherapeutic agent that is commonly associated with hand and foot syndrome. It is more commonly used as an antiviral agent.
**Option C:** This option is incorrect because it is not a chemotherapeutic agent that is commonly associated with hand and foot syndrome. It is more commonly used as an antineoplastic agent.

**Clinical Pearl / High-Yield Fact**
Hand and foot syndrome is a dose-limiting toxicity of certain chemotherapeutic agents, and its severity can be mitigated by reducing the dose or switching to a different agent. It is also more common in patients with pre-existing skin conditions or those who are taking medications that can cause photosensitivity.

**Correct Answer:** A. Capecitabine